Episode 24 of The Pound of Cure Weight Loss podcast is titled, Zepbound to happen: More Drug Shortages. The title comes from our Economics of Obesity segment where we discuss the Zepbound shortages and offer strategies that you can use to ride out the shortage.

In our In the news segment, we discuss an article from the New York Times titled, The Miracle Weight-Loss Drug Is Also a Major Budgetary Threat. In the United States, we pay more for medication than any other country in the world - often 3-4 times more. So, what can we do to bring those prices down? Tune in to find out!

In our Patient Story, we talk to Janet who started gaining weight after pregnancy. She lost well over 100 pounds on Mounjaro and is currently using a creative dosing strategy to save money during maintenance.

For the first few months after surgery and while taking a GLP-1 medications, you might not feel like eating but your body still needs fuel. So, in our Nutrition segment, Zoe offers advice about what to do when you just don’t feel like eating.

Finally, we answer 3 of our listeners' questions including, how to transition from weight loss to weight maintenance, why does a revision carry more risk, and how to keep your set point lower while on weight gaining medications.

Episode 23 of the Pound of Cure Weight Loss Podcast is titled, Big Food, Big Pharma, Big Lies. The title comes from our In the News segment where we discuss an article we found on Yahoo that talks about how big food makers like General Mills are paying social media dietitian influencers to push their products as part of the anti-diet movement. They are actually telling people that products like Coco Puffs are part of a healthy lifestyle! Insane!

In our Patient Story, we talk to Lupe who came to us on a recommendation from her Primary Care Physician. She ended up having a Gastric Bypass and needed GLP-1 medications to increase her weight loss. She is now helping her whole family make positive changes in their lives.

In our Nutrition segment we talk about the single most important strategy to elicit support from your friends and family on your weight loss journey.

In our Economics of Obesity segment we dive into how the gaming of the drug patent process played a role in the generic drug release timeline for Ozempic. It’s Part 2 of our two-part series on drug patents and in it we’ll share when Ozempic will be eligible for a generic version.

Finally, we answer 3 questions from our listeners including, serving size after surgery, compounding pharmacies, and what comes after the Metabolic Reset Diet.

Episode 22 of The Pound of Cure Weight Loss podcast is titled, Hot Diggity Dog - Costco’s New Weight Loss Program. The name comes from our In the News segment where we talk about how Costco is entering the medical weight loss space. We dive into what this means for GLP-1 access and whether or not patients benefit.

In our Patient Story segment, we talk to Suzanne who gained weight later in life after an early and then late pregnancy. She had some moderate success losing weight on her own but ended up hitting a stall that she couldn’t overcome so she reached out to us for help.

Zoe shares a strategy on how to incorporate new habits in our Nutrition segment. And Dr. Weiner begins a two-part series on drug patents in our Economics of Obesity segment. Part 1 focuses on how drug patents work and how the system can be manipulated to favor the pharmaceutical companies over patient care. Part 2 will air next week.

We also answer 3 listener submitted questions including, homemade pizza made with cauliflower crust, veggies, and vegan cheese, our thoughts on Contrave, and diagnostic pattern dumping after surgery.

Finally, some exciting news this week! We have added a new Weight Regain program to the practice. This program incorporates the expertise of both myself and Zoe and utilizes nutrition, GLP-1 medication, and behavior modification to help you lose the regain and keep it off. Plus! It’s available to anyone in the country.